Duration of late-follicular elevated progesterone and

clinical pregnancy duration in vitro fertilization infertility late-follicular elevated progesterone

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 14 03 2023
accepted: 25 05 2023
medline: 7 7 2023
pubmed: 5 7 2023
entrez: 5 7 2023
Statut: epublish

Résumé

The objective of this study was to explore whether the duration of LFEP (late-follicular elevated progesterone) affected pregnancy outcomes in IVF ( Patients with their first IVF/ICSI cycles between January 2016 and December 2016 were included. LFEP was set either at P > 1.0ng/ml or P > 1.5ng/ml. Clinical pregnancy rate was compared among three different groups (no LFEP; LFEP for 1 day; LFEP for ≥ 2 days). Then multivariate logistic regression analysis was performed to explore the influencing factors of clinical pregnancy rate. This retrospective analysis involved 3,521 first IVF/ICSI cycles with fresh embryo transfers. Clinical pregnancy rate was the lowest in patients with a LFEP duration of ≥ 2 days, irrespective of whether LFEP was defined as P > 1.0 ng/ml (68.79% vs. 63.02% vs. 56.20%; LFEP adversely affects clinical pregnancy outcomes. However, the duration of LFEP seems to have no influence on the clinical pregnancy rate in pituitary downregulation treatment cycles.

Sections du résumé

Background
The objective of this study was to explore whether the duration of LFEP (late-follicular elevated progesterone) affected pregnancy outcomes in IVF (
Method
Patients with their first IVF/ICSI cycles between January 2016 and December 2016 were included. LFEP was set either at P > 1.0ng/ml or P > 1.5ng/ml. Clinical pregnancy rate was compared among three different groups (no LFEP; LFEP for 1 day; LFEP for ≥ 2 days). Then multivariate logistic regression analysis was performed to explore the influencing factors of clinical pregnancy rate.
Results
This retrospective analysis involved 3,521 first IVF/ICSI cycles with fresh embryo transfers. Clinical pregnancy rate was the lowest in patients with a LFEP duration of ≥ 2 days, irrespective of whether LFEP was defined as P > 1.0 ng/ml (68.79% vs. 63.02% vs. 56.20%;
Conclusion
LFEP adversely affects clinical pregnancy outcomes. However, the duration of LFEP seems to have no influence on the clinical pregnancy rate in pituitary downregulation treatment cycles.

Identifiants

pubmed: 37404305
doi: 10.3389/fendo.2023.1186146
pmc: PMC10315613
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1186146

Informations de copyright

Copyright © 2023 Zhang, Ge and Bu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Reprod Biomed Online. 2004 Feb;8(2):183-90
pubmed: 14989795
Reprod Biomed Online. 2019 Apr;38(4):647-654
pubmed: 30593439
Hum Reprod. 2021 Aug 18;36(9):2463-2472
pubmed: 34223890
Reprod Biomed Online. 2011 Aug;23(2):187-95
pubmed: 21665546
J Assist Reprod Genet. 2015 Jun;32(6):951-7
pubmed: 25925350
Fertil Steril. 2017 Mar;107(3):671-676.e2
pubmed: 28069176
Fertil Steril. 2018 Apr;109(4):577-582
pubmed: 29653703
Hum Reprod. 2017 Mar 1;32(3):643-652
pubmed: 28158500
Biol Reprod. 2015 Oct;93(4):87
pubmed: 26333993
Reprod Biomed Online. 2012 May;24(5):511-20
pubmed: 22417667
Fertil Steril. 2011 Nov;96(5):1112-5
pubmed: 21924414
Hum Reprod Update. 2007 Jul-Aug;13(4):343-55
pubmed: 17405832
J Assist Reprod Genet. 2015 Feb;32(2):171-6
pubmed: 25428436
Arch Gynecol Obstet. 2021 Feb;303(2):581-587
pubmed: 32918591
PLoS One. 2014 Jun 13;9(6):e100011
pubmed: 24926883
Fertil Steril. 2015 Mar;103(3):669-74.e3
pubmed: 25544249
BMC Pregnancy Childbirth. 2021 May 6;21(1):363
pubmed: 33957886
Hum Reprod. 2012 Jul;27(7):2036-45
pubmed: 22561057
Fertil Steril. 2012 Jun;97(6):1321-7.e1-4
pubmed: 22494924
Hum Reprod Update. 2013 Sep-Oct;19(5):433-57
pubmed: 23827986
Syst Biol Reprod Med. 2015;61(6):388-97
pubmed: 26247832
J Ovarian Res. 2021 Jan 12;14(1):14
pubmed: 33436055
Hum Reprod Open. 2021 Apr 14;2021(2):hoab011
pubmed: 33880420

Auteurs

Jiaxin Zhang (J)

Reproductive Medical Center, Henan Province Key Laboratory for Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Xiaofei Ge (X)

Reproductive Medical Center, Henan Province Key Laboratory for Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Zhiqin Bu (Z)

Reproductive Medical Center, Henan Province Key Laboratory for Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH